Houston-based Incuentro provides online education with individuals with Autism, ADD, Asperger's, social anxiety, or learning differences — as well as parents or employers. Getty Images

A Houston-based online platform is hoping to provide easy access to special education resources to support individuals with special needs, as well as their employers, teachers, and caregivers — or anyone with internet access.

The online program, Incuentro, launched April 1, coinciding with the start of Autism Awareness Month. The first 15 classes are slated to go live in June. These virtual classes are intended to be a resource for people from first grade all the way through adulthood who are coping with Autism, ADD, Asperger's, social anxiety, or learning differences.

"Over 30 students participated in the pilot program over the past 9 months," says Wendy Dawson, founder of Incuentro. "I've seen students relate to the lessons, make connections with the topics, engage in peer conversation, and find support and learning in a safe environment."

Students learn and practice skills applicable to school, employment, and social situations in the virtual company of a qualified teacher and peers from the comfort of their own home. The teaching style is as interactive as possible and requires participants to engage in discussion.

Life education
Dawson says that students will get the most out of this experience if they are verbal, able to sustain attention, and participate in a video conference forum. Hour-long classes focus on friendship, behavior, social interactions in the primary and elementary years, while tweens focus on making peer connections.

"We want to provide help upfront to reduce the anxiety and depression that we commonly see later in life," Dawson says.

Teen classes set up students with skills for future employment and transitions post-high school. Adult learners benefit from job skills and workplace behavior norms.

Students who are employed or looking for employment learn about topics like conversing with coworkers and supervisors, appropriate social interactions, and understanding the rules of the workplace. Equally important, teachers discuss with participants ways that they can be their own advocate as they maneuver through society.

A focus on inclusion
Incuentro offers employer training as well, to help foster a climate of inclusion in the workplace, to discourage a lowering of expectations when accommodating employees with Autistic traits. Classes give supervisors understanding and practicalities that will foster a positive environment for employees who are also enrolled in the course.

"Employers are coached on topics such as: understanding a literal mind, being factual, making simple accommodations like visual schedules, delivering information in a low-stress manner, and understanding learning styles," Dawson says.

Incuentro helps to bridge the gap between the service and people in need through technology.

"There is a huge disconnect between the people who need services, and the actual resources. Many times they don't know where to go, or are too far away to access them."

All you need is internet access
Accessing the classes remotely removes the barrier of accessibility for people in rural areas, as well as people who would rather not drive to a class after a long day at work or school. Oftentimes, students will feel more comfortable participating in a one-hour, online discussion with 5-7 peers, rather than enduring the social pressures of a classroom setting.

"Our desire is to bring access to special education expertise to anywhere there is Wi-Fi," says Dawson.

Incuentro curriculum is created by Education Visionary Specialist Brandi Timmons, a Board Certified Behavior Analyst (BCBA) and a Licensed Behavior Analyst (LBA). Classes are taught by expert teachers who specialize in special needs education.

Family business
Dawson's passion behind Incuentro was inspired by her step-son, Cameron Dawson, who was diagnosed with Autism at the age of two.

"There were no services to fit his needs available in the market," Dawson says, "so we've spent 10 years advocating and learning, and figuring out how to best bring services to people who need them."

Cameron participated in the Incuentro pilot program while attending Texas Tech, and in May he will be graduating with his degree in Communication Studies. Upon returning home to Houston, he will be seeking a job in one of many local churches, where Dawson says he has experienced love and support throughout his life.

As a mother of a child with Autism and advocate for people with special needs, Dawson has seen the challenges faced by parents. Parents not only must navigate the ups and downs of school life and home life with their child each step of the way, but also plan next steps past high school graduation, and long-term care, if necessary. Incuentro helps to facilitate the discussion and provide resources for caregivers wanting to learn what options are available.

With April designated as Autism Awareness Month, Incuentro seeks to partner with organizations serving special needs populations, such as school districts, health clinics, or Autism support networks, and reach the people who need it most. Incuentro has pledged to donate a portion of its profits to a Houston non-profit that offers in-person classes for people with special needs, Social Motion. At its heart, Incuentro intends to be an answer to the question: how do we set individuals with special needs up for success, and help give them the tools to live an independent and fulfilling life?

Brandi Timmons (left) and Wendi Dawson, Incuentro founderCourtesy of Incuentro

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.